RPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acquisitions, Managing Director Ashok Nair said. The drugmaker has committed Rs 700 crore for expansion and targets Rs 2,000-2,500 crore revenue by 2030, supported by domestic and international growth.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.